Supporting data for "Dendrimer nanoparticles in anticancer treatment applications"

This data is used in the PhD thesis "Dendrimer nanoparticles in anticancer treatment applications" and contain the findings about in vitro and in vivo efficacy and toxicity of dendrimer-enhanced small molecules and siRNAs. We used dendrimer nanoparticles as anti-LMP1 siRNA carriers for nasopharyngeal carcinoma targeted therapy, and applied bola-lipid dendrimers as vehicles for imatinib mesylate to successfully inhibit ovarian cancer stem cells, both in vitro and in vivo, without serious adverse effects.